VSORA
Venture Round in 2025
VSORA develops digital signal processing IP and chips for 5G networks, featuring a multicore DSP architecture that removes the need for DSP coprocessors and a shared DSP development flow that unites signal processing and software engineers in one environment to speed time-to-market. The company aims to boost DSP computing power while reducing power consumption, improving system performance, and shrinking silicon footprint. Based in France, founded in 2015 by veteran DSP engineers, VSORA serves chipmakers designing next-generation digital communications systems.
ARX Robotics
Series A in 2025
ARX is a defense technology company that specializes in the development of autonomous unmanned systems for dual-use applications.
Sekoia.io
Series B in 2025
Sekoia.io is a developer of an advanced security operations center (SOC) platform that equips security teams with tools to effectively identify and respond to significant cyber threats across their entire attack surface. The platform integrates real-time detection and automation, allowing teams to manage the complexities and high volumes of security incidents while reducing false positives. By continuously analyzing emerging threats and implementing strategic responses, Sekoia.io enables organizations to enhance their security posture and respond to threats more swiftly and reliably than traditional security information and event management (SIEM) systems. This proactive approach ensures that clients remain informed and prepared against evolving cyber risks.
Coave Therapeutics
Series A in 2025
Coave Therapeutics specializes in developing gene therapies for rare ocular and central nervous system (CNS) diseases. Its platform enables targeted delivery of therapeutic genes to the CNS, enhancing autophagy and lysosomal function, with a focus on improving patient outcomes for conditions like ALS.
Planet A Foods
Series B in 2024
Planet A Foods specializes in producing cocoa-free chocolate. The company focuses on local food production with minimal environmental impact, aiming to reduce global carbon emissions.
The Exploration Company
Series B in 2024
The Exploration Company designs, builds, and operates modular, reusable spacecraft named Nyx for use on space stations near Earth and the Moon. Nyx can be refueled in orbit and uses green propellants. The company also provides an open-source operating system for these spacecraft. By offering in-space experiments on the International Space Station at a minimum price, it aims to make space exploration more accessible and enable new players to participate in the space exploration race.
Qantev operates a health claims platform that leverages artificial intelligence to optimize insurer claims operations. Its proprietary algorithm helps configure provider networks and reduce claims leakage, enabling data-driven decision-making for global health insurance businesses.
Carbyon is a Dutch company specializing in direct air capture (DAC) technologies. It filters CO2 from the atmosphere, purifies it, and supplies it to produce kerosene for aircraft, enabling the existing fossil industry to repurpose storage and transport facilities for renewable hydrocarbons.
Unseenlabs
Series C in 2024
Founded in 2015, Unseenlabs specializes in marine surveillance services. It designs and develops satellite payloads to detect and track non-cooperative vessels worldwide, even when they disable their Automatic Identification System. The company offers turnkey solutions, providing information from satellite design to launch.
EEF Erneuerbare Energien Fabrik
Acquisition in 2024
EEF Erneuerbare Energien Fabrik is a power generation company specializing in renewable energy. It develops, implements, and operates wind energy and photovoltaic projects, along with energy storage solutions, to facilitate the decarbonization of the energy market. The company also employs AI software to enhance its operations.
GEEV
Venture Round in 2024
GEEV is a collaborative mobile application that facilitates the donation and collection of various items among its users, promoting a culture of sharing and reducing waste. The platform allows individuals to donate objects they no longer need and to retrieve free items from others in their community. By providing features for communication and coordination, GEEV fosters interaction between users, enabling them to discuss and arrange meetups for the exchange of goods. The app not only helps users declutter but also encourages sustainable practices by giving objects a second life, thereby contributing to waste reduction efforts.
Planet A Foods
Series A in 2024
Planet A Foods specializes in producing cocoa-free chocolate. The company focuses on local food production with minimal environmental impact, aiming to reduce global carbon emissions.
Quandela is a company focused on advancing quantum computing technology, specifically in the realms of communication networks and optical computers. It specializes in manufacturing photonic quantum computers, which it supplies to industrial clients. A key innovation from Quandela is its single-photon source device, which integrates photonics with semiconductor quantum dots. This device enables the efficient collection of emitted single photons at high rates, significantly reducing charge noise decoherence and facilitating the emission of identical photons with high fidelity. Such capabilities are essential for the development of advanced quantum applications in communication, computation, and sensing, positioning Quandela as a pivotal player in the quantum technology landscape.
Quantum Systems
Series B in 2023
Quantum system develops manufactures and sells unmanned aerial systems, which provide aerial intelligence to commercial and governmental clients around the world.
Corteria Pharmaceuticals
Series A in 2023
Corteria Pharmaceuticals is a biotechnology company dedicated to developing innovative therapies for heart failure subpopulations, particularly focusing on acute decompensated heart failure. The company aims to address unmet medical needs by creating first-in-class drugs that enhance the understanding of disease biology among medical professionals. In addition to heart failure, Corteria also explores treatments for related conditions, such as sarcopenia and obesity, to improve patient outcomes and provide effective solutions for complex health issues. Through its research and development efforts, Corteria Pharmaceuticals seeks to transform the landscape of heart failure treatment.
PeopleSpheres
Venture Round in 2023
PeopleSpheres is a Paris-based company that specializes in providing a comprehensive human resources information system (HRIS) software solution designed to meet the diverse needs of businesses. Founded in 2010 and originally named NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. The software solution offered by PeopleSpheres is tailored to be suitable, sustainable, and scalable, addressing the specific challenges faced by organizations in HR management. To enhance its offerings, PeopleSpheres collaborates with leading national HR service providers, particularly targeting American businesses. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS, further solidifying its position in the HR technology space.
Sekoia.io
Series A in 2023
Sekoia.io is a developer of an advanced security operations center (SOC) platform that equips security teams with tools to effectively identify and respond to significant cyber threats across their entire attack surface. The platform integrates real-time detection and automation, allowing teams to manage the complexities and high volumes of security incidents while reducing false positives. By continuously analyzing emerging threats and implementing strategic responses, Sekoia.io enables organizations to enhance their security posture and respond to threats more swiftly and reliably than traditional security information and event management (SIEM) systems. This proactive approach ensures that clients remain informed and prepared against evolving cyber risks.
DiogenX is a French biotechnology company founded in 2019, focused on developing therapeutic solutions for diabetic patients. It specializes in pancreatic beta-cell modulators for treating Type 1 and Type 2 diabetes by regenerating insulin-producing cells.
Iktos is a French company specializing in artificial intelligence-driven solutions for medicinal chemistry and new drug discovery. It offers SaaS platforms Makya™ for generative drug design and Spaya™ for retrosynthesis, accelerating pharmaceutical R&D. Iktos also develops AI-driven synthesis automation platform Iktos Robotics and has its own drug pipeline targeting oncology and autoimmune diseases.
The Exploration Company
Series A in 2023
The Exploration Company designs, builds, and operates modular, reusable spacecraft named Nyx for use on space stations near Earth and the Moon. Nyx can be refueled in orbit and uses green propellants. The company also provides an open-source operating system for these spacecraft. By offering in-space experiments on the International Space Station at a minimum price, it aims to make space exploration more accessible and enable new players to participate in the space exploration race.
VSORA
Venture Round in 2023
VSORA develops digital signal processing IP and chips for 5G networks, featuring a multicore DSP architecture that removes the need for DSP coprocessors and a shared DSP development flow that unites signal processing and software engineers in one environment to speed time-to-market. The company aims to boost DSP computing power while reducing power consumption, improving system performance, and shrinking silicon footprint. Based in France, founded in 2015 by veteran DSP engineers, VSORA serves chipmakers designing next-generation digital communications systems.
Opensee is a Paris-based fintech company that specializes in providing self-service analytics solutions for financial institutions. Founded by a team of experts from the financial and technology sectors, Opensee addresses the challenges posed by big data by enabling organizations to efficiently analyze vast quantities of data on demand. The platform allows business users to perform in-depth analyses and what-if scenarios, facilitating better decision-making in areas such as risk management in capital markets and resource management in commercial and retail banking. By transforming complex data into actionable insights, Opensee empowers financial institutions to enhance their market intelligence and streamline regulatory reporting processes.
Dust Mobile
Series B in 2022
Founded in 2017, Dust Mobile operates as a secure-by-design global carrier specializing in cybersecurity solutions for mobile networks. It offers comprehensive protection against cellular network threats and cyber-attacks, safeguarding voice, text, data communications, and SIM cards across 2G, 3G, 4G LTE, and 5G networks.
Qantev operates a health claims platform that leverages artificial intelligence to optimize insurer claims operations. Its proprietary algorithm helps configure provider networks and reduce claims leakage, enabling data-driven decision-making for global health insurance businesses.
Founded in Paris, France in 2019, GOURMEY specializes in developing and producing ethical foie gras using duck cell cultivation. This innovative process aims to create sustainable, high-quality meat products without force-feeding or animal slaughter.
Founded in 2013, Ternoa specializes in blockchain technology for secure, anonymous, and intermediary-free data transfer. Its platform ensures long-term data integrity through decentralized storage providers and multi-party cryptography.
WhiteLab Genomics
Seed Round in 2022
WhiteLab Genomics develops a proprietary platform that uses graph knowledge technology and machine learning to aid in the discovery and design of new genomic therapies. It helps scientists optimize payloads, vectors, experimental protocols, and assess genotoxicity, accelerating drug development.
Qubit Pharmaceuticals
Seed Round in 2022
Qubit Pharmaceuticals is a Paris-based drug discovery company established in 2020. It develops a simulation platform that reduces the cost and duration of preclinical development by using proprietary force field models and molecular dynamics to perform virtual screening and visualization, enabling the identification of viable drug candidates. The platform applies quantum physics-inspired modeling to support biopharmaceutical research and aims to translate advanced computational methods into practical tools for drug development.
Therapixel
Series B in 2022
Therapixel SA is a company based in Valbonne, France, with additional locations across multiple countries, including Australia and China. Founded in 2013, Therapixel specializes in designing and developing medical image analytics software for surgeons, leveraging artificial intelligence to enhance surgical procedures. Their product portfolio includes Radvise, an automatic image reading solution; Fluid, a touchless medical image navigation system for surgery; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing CDs from outpatient imaging exams. The company also focuses on AI-based software for breast cancer detection and characterization, providing healthcare professionals with pertinent information to support decision-making during surgeries while adhering to sterility constraints.
Domain Therapeutics
Series A in 2022
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G protein-coupled receptors (GPCRs), which are key drug targets in various diseases. Founded in 2001, the company specializes in developing small molecules for the treatment of central nervous system (CNS) disorders and cancer. It employs its proprietary technology platform, DTect-All, which enables the identification of orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs) that are challenging to discover using conventional methods. In addition, Domain Therapeutics offers BioSens-All, a platform to explore the signaling complexities associated with GPCR activation, enhancing its ability to address difficult targets, such as orphan and peptidic GPCRs.
TagEnergy
Venture Round in 2022
TagEnergy is a clean energy enterprise for a new cycle in the renewable energy industry. It was formed in 2019 to accelerate the energy transition by developing and investing in competitive and clean power stations in order to compete directly and actively on the energy markets.
Renewables have now become the main source of energy able to provide both social responsibility and price efficiency, and we are delivering this in the countries where we have established our activity.
TagEnergy is operated by a highly-experienced team of manager-shareholders. Its operations span the renewables value chain, from development, financing, construction and asset management of wind, solar and storage projects, to commercialisation of its competitive energy.
TagEnergy has developed a portfolio of 2.7GW in the UK, Australia, Spain, Portugal and France, and intends to drive the pace of transition through projects that deliver reliable energy affordably, and at scale.
Skillup
Venture Round in 2022
Skillup is a developer of educational training and talent management software that enables researching, comparing, and booking professional training courses. The platform includes a reservation engine, online publication, and SaaS tools to streamline the management of training, interviews, and skills. It serves employers and HR managers by simplifying the design and implementation of company training plans, supporting talent engagement, growth, and retention. The platform also operates a marketplace-style service hosting thousands of trainings and reviews to help users identify suitable programs for employees.
SeqOne Genomics
Series A in 2022
SeqOne S.A.S. is a company based in Montpellier, France, that specializes in developing genomic data analysis software for the healthcare industry. Founded in 2017, SeqOne's platform offers end-to-end management of next-generation sequencing (NGS) and bioinformatics data, providing advanced tools for analyzing complex genomic information. The software is designed to deliver medically actionable results across various areas, including oncology, hematological diseases, rare diseases, genetic screening, and hereditary conditions. By addressing the challenges associated with analyzing rich genomic data, SeqOne aims to enhance the accessibility and effectiveness of genomic medicine, thereby facilitating improved treatment options for patients. The company serves both private and public healthcare sectors, contributing to the ongoing transformation of healthcare through the integration of genomic insights.
AlgoTherapeutix
Series B in 2022
AlgoTherapeutix develops topical treatments for complex pain conditions, focusing on chemotherapy-induced peripheral neuropathy and diabetic neuropathic pain. The company repurposes existing drugs to target damaged nerve fibers in the skin, avoiding systemic side effects of oral drugs.
Corteria Pharmaceuticals
Seed Round in 2021
Corteria Pharmaceuticals is a biotechnology company dedicated to developing innovative therapies for heart failure subpopulations, particularly focusing on acute decompensated heart failure. The company aims to address unmet medical needs by creating first-in-class drugs that enhance the understanding of disease biology among medical professionals. In addition to heart failure, Corteria also explores treatments for related conditions, such as sarcopenia and obesity, to improve patient outcomes and provide effective solutions for complex health issues. Through its research and development efforts, Corteria Pharmaceuticals seeks to transform the landscape of heart failure treatment.
Quandela
Venture Round in 2021
Quandela is a company focused on advancing quantum computing technology, specifically in the realms of communication networks and optical computers. It specializes in manufacturing photonic quantum computers, which it supplies to industrial clients. A key innovation from Quandela is its single-photon source device, which integrates photonics with semiconductor quantum dots. This device enables the efficient collection of emitted single photons at high rates, significantly reducing charge noise decoherence and facilitating the emission of identical photons with high fidelity. Such capabilities are essential for the development of advanced quantum applications in communication, computation, and sensing, positioning Quandela as a pivotal player in the quantum technology landscape.
Coave Therapeutics
Series B in 2021
Coave Therapeutics specializes in developing gene therapies for rare ocular and central nervous system (CNS) diseases. Its platform enables targeted delivery of therapeutic genes to the CNS, enhancing autophagy and lysosomal function, with a focus on improving patient outcomes for conditions like ALS.
Prima Vital
Seed Round in 2021
Prima Vital provides financing advice and assistance, delivery and installation of safety equipment, after-sales service, and warranty and maintenance of installations. Their customers' inquiries are addressed through phone, email, and online applications.
Ilmatar Energy
Venture Round in 2021
Ilmatar Energy specializes in developing, constructing, and operating onshore wind farms to produce renewable energy. It focuses on long-term Power Purchase Agreements (PPAs) to ensure stable energy supply and contributes significantly to the energy transition.
Unseenlabs
Series B in 2021
Founded in 2015, Unseenlabs specializes in marine surveillance services. It designs and develops satellite payloads to detect and track non-cooperative vessels worldwide, even when they disable their Automatic Identification System. The company offers turnkey solutions, providing information from satellite design to launch.
PeopleSpheres
Venture Round in 2021
PeopleSpheres is a Paris-based company that specializes in providing a comprehensive human resources information system (HRIS) software solution designed to meet the diverse needs of businesses. Founded in 2010 and originally named NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. The software solution offered by PeopleSpheres is tailored to be suitable, sustainable, and scalable, addressing the specific challenges faced by organizations in HR management. To enhance its offerings, PeopleSpheres collaborates with leading national HR service providers, particularly targeting American businesses. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS, further solidifying its position in the HR technology space.
Elistair SAS, founded in 2014 and based in Champagne-au-Mont-d'Or, France, specializes in designing and manufacturing industrial tethered drone systems. The company offers products such as SAFE-T and LIGH-T, which provide real-time persistent observation and aerial capabilities, respectively. These systems enable extended flight times, enhanced safety, and secure high-speed data transfer, making them ideal for various applications, including public safety, private security, traffic monitoring, national security, and law enforcement. Elistair's innovative technology has been deployed in over 30 countries and has garnered several awards, including the 2016 Technology Innovation Award from Frost & Sullivan, establishing the company as a leader in the UAV market.
Artifakt is a developer of cloud application tools that streamline the deployment, management, and operation of web projects within modern cloud infrastructures. The company's platform allows digital teams to configure environments quickly and automate various processes, enabling developers to concentrate on writing, testing, and improving their code. By simplifying cloud deployment, Artifakt empowers teams to work autonomously, significantly enhancing efficiency and accelerating project timelines. This approach not only optimizes the deployment experience but also allows talented developers to focus on their core passion: building innovative web applications.
AgomAb Therapeutics
Series B in 2021
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.
Bizay is a technology platform that provides an extensive catalogue of customizable products, operating across Europe, North and South America. The company focuses on digitalizing the product customization industry, allowing local manufacturers, brands, and wholesalers to offer a wide range of customizable items. Bizay targets multiple customer segments, including businesses seeking to sell customized products, small and medium-sized enterprises needing specific product solutions, and major brands leveraging the company's technology for their own customization needs. Its offerings encompass various product categories, such as promotional items, packaging, home and garden goods, fashion and sports products, and beauty and health items. Moreover, Bizay emphasizes sustainability and social responsibility, collaborating with partners that implement inclusion programs and utilizing recycled materials in its products. By optimizing supply chain processes, the company significantly reduces production costs, making customization accessible for a diverse clientele.
AlgoTherapeutix
Series A in 2020
AlgoTherapeutix develops topical treatments for complex pain conditions, focusing on chemotherapy-induced peripheral neuropathy and diabetic neuropathic pain. The company repurposes existing drugs to target damaged nerve fibers in the skin, avoiding systemic side effects of oral drugs.
Power Capital Renewable Energy
Acquisition in 2020
Founded in 2011, Power Capital Renewable Energy specializes in developing, operating, and managing large-scale photovoltaic solar farms. The company focuses on acquiring, designing, financing, building, and operating utility-scale solar parks to deliver clean, reliable green electricity.
Biosyl
Venture Round in 2020
Biosyl SAS is a holding company based in Cosne-Cours-sur-Loire, France, founded in 2010. It specializes in the production of wood energy and fuel wood pellets, utilizing waste and wood scrap to create low-emission energy solutions. Through its subsidiary, Biosyl operates a pellet production plant capable of processing logs into pellets, achieving an annual production capacity exceeding one hundred thousand tons. This innovative approach not only helps in recovering local coppice wood but also enables customers to reduce their carbon footprint by transforming wood waste into energy with minimal CO2 emissions.
Sekoia.io
Series A in 2020
Sekoia.io is a developer of an advanced security operations center (SOC) platform that equips security teams with tools to effectively identify and respond to significant cyber threats across their entire attack surface. The platform integrates real-time detection and automation, allowing teams to manage the complexities and high volumes of security incidents while reducing false positives. By continuously analyzing emerging threats and implementing strategic responses, Sekoia.io enables organizations to enhance their security posture and respond to threats more swiftly and reliably than traditional security information and event management (SIEM) systems. This proactive approach ensures that clients remain informed and prepared against evolving cyber risks.
AB Tasty is a Paris-based software company that provides a cloud-based platform for experimentation, personalization, and product optimization. The platform supports marketing, product, and technical teams by collecting online usage data and turning website, mobile, and application visitors into customers, subscribers, and leads. It offers feature management, A/B, multivariate, and multipage testing, along with personalization and engagement tools to improve conversion rates, user experiences, and revenue across digital assets and channels. The solution is designed for industries such as e-commerce, retail, travel, luxury and fashion, media, and financial services. Founded in 2009, AB Tasty helps teams launch better products faster and act on customer insights to optimize performance.
Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.
Biofutur
Acquisition in 2020
Biofutur operates a network of medical biology analysis laboratories primarily in France. It offers a wide range of services including medical consultations, hematology, allergology, immunoassays, and embryo transfer, contributing to patient care by providing comprehensive examination results.
Dust Mobile
Venture Round in 2019
Founded in 2017, Dust Mobile operates as a secure-by-design global carrier specializing in cybersecurity solutions for mobile networks. It offers comprehensive protection against cellular network threats and cyber-attacks, safeguarding voice, text, data communications, and SIM cards across 2G, 3G, 4G LTE, and 5G networks.
TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.
Solvionic
Venture Round in 2019
Founded in 2003, Solvionic is a French technology company specializing in the development and manufacturing of ionic liquid chemicals. These products cater to various industries including pharmaceuticals, petrochemicals, and electrochemistry. The company's innovative approach focuses on sustainable chemistry, aiming to reduce energy consumption, raw materials, and waste generation.
Biosyl
Venture Round in 2019
Biosyl SAS is a holding company based in Cosne-Cours-sur-Loire, France, founded in 2010. It specializes in the production of wood energy and fuel wood pellets, utilizing waste and wood scrap to create low-emission energy solutions. Through its subsidiary, Biosyl operates a pellet production plant capable of processing logs into pellets, achieving an annual production capacity exceeding one hundred thousand tons. This innovative approach not only helps in recovering local coppice wood but also enables customers to reduce their carbon footprint by transforming wood waste into energy with minimal CO2 emissions.
Newronika
Series A in 2019
Newronika develops innovative neuro-modulation devices aimed at restoring brain and body functions. The company translates its deep expertise in biosignal decoding into clinical practice, enabling patients to receive targeted stimulation for improved daily activities and enhanced quality of life.
Wizaplace
Venture Round in 2019
Founded in 2012, Wizaplace is a French software company that provides an all-in-one SaaS platform for creating and managing marketplaces. Its solution integrates essential functions for building and operating B2C, B2B, C2C, and tailor-made service marketplaces, along with e-commerce, crowdfunding, and collaborative platforms.
Themis Bioscience
Series D in 2019
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company headquartered in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead product candidate, MV-CHIK, has completed Phase II clinical trials for chikungunya treatment. Themis is also engaged in developing vaccines for various health threats, including cancer, Zika virus, Lassa fever, and MERS. Themis leverages its advanced understanding of immune system mechanisms through its innovative vaccine platform, focusing on both emerging and specialized indications. The company has established research collaborations and exclusive licensing agreements to enhance its development capabilities, positioning itself as a strategic partner for leading biotechnology and pharmaceutical firms.
SPHEREA
Venture Round in 2019
SPHEREA specializes in providing modular testing solutions for manufacturers, equipment suppliers, integrators, and operators across various industries. Their offerings include model-based testing, field test equipment, wiring testers, and maintenance support services.
Bankin' is a European leader in mobile money management, serving over 1.5 million users across France, England, Spain, and Germany. It offers an independent, user-centric platform that combines intelligent algorithms with human coaching to provide personalized savings, credit, and insurance options.
NH TherAguix
Series A in 2019
NH TherAguix SAS is a clinical-stage pharmaceutical company based in Villeurbanne, France, focused on the development of nanomedicines for cancer treatment. The company specializes in creating innovative therapeutics that enhance radiotherapy for solid tumors. Its lead product, AGuIX, is a theranostic nanoparticle designed to improve the localization of tumors and optimize radiation therapy outcomes. By facilitating intravenous administration, AGuIX enables healthcare professionals to determine the best timing for irradiation, targets tumor tissues more effectively, and minimizes adverse effects on healthy tissues by reducing radiation doses. Founded in 2015, NH TherAguix is dedicated to advancing cancer treatment through its pioneering approach to combining imaging and radiotherapy.
AgomAb Therapeutics
Series A in 2019
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.
Therapixel
Series A in 2019
Therapixel SA is a company based in Valbonne, France, with additional locations across multiple countries, including Australia and China. Founded in 2013, Therapixel specializes in designing and developing medical image analytics software for surgeons, leveraging artificial intelligence to enhance surgical procedures. Their product portfolio includes Radvise, an automatic image reading solution; Fluid, a touchless medical image navigation system for surgery; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing CDs from outpatient imaging exams. The company also focuses on AI-based software for breast cancer detection and characterization, providing healthcare professionals with pertinent information to support decision-making during surgeries while adhering to sterility constraints.
Teach on Mars
Venture Round in 2019
Teach on Mars SAS is a leading provider of mobile learning technology based in Sophia Antipolis, France, with additional offices in Paris, Milan, and London. Founded in 2013, the company has established itself as a prominent player in the mobile learning sector, delivering solutions to over 100 clients in more than 60 countries and in 20+ languages. The platform enables organizations to create mobile courses and learning games, manage training programs, and analyze learner progress through comprehensive analytics. Teach on Mars offers various applications, including Learn on Mars for personalized learning experiences and Quiz on Mars, which promotes engagement through social learning games. Additionally, the company provides training, certification, and support services, as well as integration and professional content marketplace solutions. With a dedicated team and a global network of partners, Teach on Mars aims to equip organizations with the necessary tools and expertise to develop effective learning ecosystems while committing 1% of its revenues to education initiatives aligned with the UN Sustainable Development Goals.
Bizay is a technology platform that provides an extensive catalogue of customizable products, operating across Europe, North and South America. The company focuses on digitalizing the product customization industry, allowing local manufacturers, brands, and wholesalers to offer a wide range of customizable items. Bizay targets multiple customer segments, including businesses seeking to sell customized products, small and medium-sized enterprises needing specific product solutions, and major brands leveraging the company's technology for their own customization needs. Its offerings encompass various product categories, such as promotional items, packaging, home and garden goods, fashion and sports products, and beauty and health items. Moreover, Bizay emphasizes sustainability and social responsibility, collaborating with partners that implement inclusion programs and utilizing recycled materials in its products. By optimizing supply chain processes, the company significantly reduces production costs, making customization accessible for a diverse clientele.
ABMI
Venture Round in 2018
ABMI is an engineering company specializing in various technological domains. The firm provides comprehensive solutions in areas such as design, IT infrastructure, robotics, the Internet of Things (IoT), cloud computing, and cybersecurity. ABMI operates within a rapidly expanding market, leveraging its expertise across multiple disciplines to deliver innovative and effective technical services.
Captain Tortue
Funding Round in 2018
Captain Tortue is the European leader in direct selling women's ready-to-wear clothing. Every year, it designs around 330 models through its four brands: Trend (trendy collection, urban chic), Miss (classic and casual collection), Little Miss (children's collections, teenagers and small sizes) and Java (home wear comfort-casual).
Sentryo SAS is a cybersecurity company that specializes in providing solutions for industrial networks and the Internet of Things. Founded in 2014 and headquartered in Charbonnières-les-Bains, France, Sentryo focuses on ensuring the resilience and safety of industrial operations by offering continuous visibility over Industrial Control Systems (ICS) and SCADA infrastructures. The company's flagship product, ICS CyberVision, enables control engineers to monitor all equipment connected to industrial networks, identify vulnerabilities, and make informed decisions to maintain system integrity. Sentryo's solutions leverage artificial intelligence and machine learning algorithms to deliver real-time insights, detect anomalies, and manage cyber risks effectively. The company serves various sectors, including smart cities, utilities, and energy grids, making it a crucial player in securing critical infrastructures. As of 2019, Sentryo operates as a subsidiary of Cisco Systems, Inc.
Intersec
Venture Round in 2018
Intersec SA, established in 2004, is a global technology company headquartered in Paris, France, with an additional office in London, UK. It specializes in providing streaming analytics solutions to various sectors, including telecommunications, utilities, manufacturing, financial services, and retail. Intersec's offerings encompass customer base management, location data monetization, fraud management, public safety, IoT analytics, and messaging solutions. The company's solutions enable organizations to derive real-time insights from vast amounts of data, helping them to optimize operations, enhance customer experiences, and drive new revenue streams. Intersec serves over 90 clients across 40 countries, reaching nearly one billion connected devices and covering over 400 million people with its mission-critical communication solutions. Recognized by Gartner as a leading vendor in location intelligence and telecom data monetization, Intersec prioritizes privacy and regulatory compliance, ensuring it operates responsibly worldwide.
GEEV
Venture Round in 2018
GEEV is a collaborative mobile application that facilitates the donation and collection of various items among its users, promoting a culture of sharing and reducing waste. The platform allows individuals to donate objects they no longer need and to retrieve free items from others in their community. By providing features for communication and coordination, GEEV fosters interaction between users, enabling them to discuss and arrange meetups for the exchange of goods. The app not only helps users declutter but also encourages sustainable practices by giving objects a second life, thereby contributing to waste reduction efforts.
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.
Marquetis
Debt Financing in 2018
Founded in 1996, Marquetis is a French marketing and communications company offering comprehensive solutions. It provides global communication consulting, automated cross-channel marketing via SaaS, and operational services through subsidiaries like Marquetis One, Marquetis Connect, and Marquetis Call.
Tiller Systems
Series B in 2018
Tiller Systems SAS is a Paris-based company that specializes in developing cloud-based point of sale (POS) software solutions for restaurants and merchants. Founded in March 2014, Tiller's management tools enable users to accept various payment types, integrate partner applications, and effectively oversee staff and inventory in real time. The software features a mobile POS system that allows for the management of both in-store and online orders from a single platform. Additionally, Tiller offers a web dashboard that facilitates catalog updates, sales tracking, employee payments, stock alerts, customer relationship management, and access to real-time reporting and performance metrics. With additional offices in Barcelona and Milan, Tiller Systems aims to empower businesses to make informed decisions and enhance their operational efficiency.
Mistral Informatique
Acquisition in 2018
The Mistral group markets an integrated software solution (ERP) dedicated to the market and the business of dealers, renters, resellers of agricultural equipment and construction equipment. The group consists of two entities, Mistral Informatique (publisher of software and mobility applications) and Mistral DataCenter (hosting and outsourcing services).
Nanomakers
Venture Round in 2018
Founded in Paris, France in 2010, Nanomakers specializes in manufacturing silicon-based nanomaterials. Their patented nanopowders enhance mechanical properties and energy storage capacity across industries such as semiconductors, lithium-ion batteries, aerospace, and automotive.
Tilkee is a cloud-based application that enhances the efficiency of sales teams by tracking business proposals and optimizing prospect follow-up. The platform allows users to upload sales documents, create customized online proposals, and generate unique links for their prospects. It provides real-time notifications on document engagement, revealing who has viewed the proposals, the focus of their attention, and the duration of their engagement. This data-driven approach enables sales professionals to assess prospects' interest and readiness to close deals, ultimately improving their sales performance and marketing effectiveness.
Scality provides software-defined storage solutions, specializing in petabyte-scale object storage. Founded in 2009, Scality's flagship product, RING, enables businesses to store and manage vast amounts of data with high availability and performance. It serves major media, telecommunications, and cloud service providers worldwide.
ForCity is a software-as-a-service (SaaS) company that specializes in developing a decision support platform focused on urban planning and management. Utilizing advanced 3D and 4D simulation technology, ForCity's platform integrates various datasets pertaining to urban parameters such as energy consumption, water usage, real estate projects, and land availability. This comprehensive approach enables municipalities to generate detailed reports that aid in strategic planning and operational optimization. By providing valuable insights, ForCity empowers local governments to enhance their development strategies in areas such as energy management, waste reduction, land use, and economic development, ultimately contributing to the creation of smarter, more sustainable cities.
VSORA develops digital signal processing IP and chips for 5G networks, featuring a multicore DSP architecture that removes the need for DSP coprocessors and a shared DSP development flow that unites signal processing and software engineers in one environment to speed time-to-market. The company aims to boost DSP computing power while reducing power consumption, improving system performance, and shrinking silicon footprint. Based in France, founded in 2015 by veteran DSP engineers, VSORA serves chipmakers designing next-generation digital communications systems.
Pherecydes Pharma
Series B in 2018
Pherecydes Pharma specializes in the research and development of lytic bacteriophages for therapeutic applications, focusing on antibiotic resistance. Established in 2006, the company is based in Romainville, France.
Enterome
Debt Financing in 2018
Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.
Themis Bioscience
Series C in 2018
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company headquartered in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead product candidate, MV-CHIK, has completed Phase II clinical trials for chikungunya treatment. Themis is also engaged in developing vaccines for various health threats, including cancer, Zika virus, Lassa fever, and MERS. Themis leverages its advanced understanding of immune system mechanisms through its innovative vaccine platform, focusing on both emerging and specialized indications. The company has established research collaborations and exclusive licensing agreements to enhance its development capabilities, positioning itself as a strategic partner for leading biotechnology and pharmaceutical firms.
Coave Therapeutics
Series B in 2017
Coave Therapeutics specializes in developing gene therapies for rare ocular and central nervous system (CNS) diseases. Its platform enables targeted delivery of therapeutic genes to the CNS, enhancing autophagy and lysosomal function, with a focus on improving patient outcomes for conditions like ALS.
Aero Negoce International
Venture Round in 2017
Aero Negoce International, SAS, established in 1993 and headquartered in Béziers, France, specializes in manufacturing and distributing fasteners and hardware tailored for the aerospace industry. The company offers a diverse range of products, including fasteners, spherical plain bearings, connectors, lamps, seals, and hinges. In addition to its manufacturing capabilities, Aero Negoce International provides contract management, consignment stock, and custom packing services to meet the needs of its clients. Its primary customers include prominent aircraft manufacturers such as Airbus and Dassault, along with key suppliers like Zodiac and Safran, positioning the company as a vital player in the aerospace supply chain.
Groupe InCa
Acquisition in 2017
Groupe InCa SAS, founded in 1954 and headquartered in Artigues Près Bordeaux, France, is a prominent player in the construction industry within the New Aquitaine region. The company specializes in the building of custom-designed detached homes, catering to a diverse clientele that includes both first-time buyers and high-end customers. It operates under three well-established brands: Maisons Clairlande, Les Demeures de la Côte d’Argent, and Rouquié Constructions. Through its focus on quality and tailored solutions, Groupe InCa has positioned itself as a regional leader in the residential construction market.
Groupe InCa
Acquisition in 2017
Groupe InCa SAS, founded in 1954 and headquartered in Artigues Près Bordeaux, France, is a prominent player in the construction industry within the New Aquitaine region. The company specializes in the building of custom-designed detached homes, catering to a diverse clientele that includes both first-time buyers and high-end customers. It operates under three well-established brands: Maisons Clairlande, Les Demeures de la Côte d’Argent, and Rouquié Constructions. Through its focus on quality and tailored solutions, Groupe InCa has positioned itself as a regional leader in the residential construction market.
AB Tasty is a Paris-based software company that provides a cloud-based platform for experimentation, personalization, and product optimization. The platform supports marketing, product, and technical teams by collecting online usage data and turning website, mobile, and application visitors into customers, subscribers, and leads. It offers feature management, A/B, multivariate, and multipage testing, along with personalization and engagement tools to improve conversion rates, user experiences, and revenue across digital assets and channels. The solution is designed for industries such as e-commerce, retail, travel, luxury and fashion, media, and financial services. Founded in 2009, AB Tasty helps teams launch better products faster and act on customer insights to optimize performance.
Batiweb.com
Venture Round in 2017
Batiweb.com is a B2B web portal dedicated to the housing and construction sectors, positioning itself as a key player in the market. The platform serves as a digital networking hub that connects trade professionals with consumers, offering essential information on construction, renovation, and housing-related issues. Batiweb operates through three main activities: intermediation, media, and various services, which collectively address the needs of clients in the construction industry. By continuously expanding its product offerings, Batiweb aims to establish itself as the leading online group focused on construction, housing, and decoration.
RGF GROUP
Acquisition in 2017
RGF Group is a manufacturer specializing in plastic injection molding, catering to various sectors such as healthcare, sports, construction, home automation, automotive, and industrial equipment. The company utilizes advanced technology, including electric and hydraulic machines, to offer both single and bi-material injection solutions. In addition to manufacturing, RGF Group provides expertise in the design and production of injection tooling, ensuring high-quality and efficient service. With production facilities located in France and globally, RGF Group emphasizes flexibility and responsiveness to meet the industrial challenges of its clients.
MultiX
Venture Round in 2017
MultiX S.A., founded in 2010 and headquartered in Neuilly-sur-Seine, France, specializes in designing, producing, and selling spectrometric X-ray detectors. These detectors are used for material identification in various applications including security, food processing, mining, recycling, industry, and non-destructive testing. MultiX's advanced multi-energy technology is particularly beneficial for reducing false alarms in baggage screening systems at airports and sensitive infrastructure, thereby enhancing passenger facilitation and experience by minimizing the need to remove liquids and laptops from hand baggage while adhering to stringent security regulations. The company supplies system manufacturers with this technology, enabling them to improve operational efficiency and meet regulatory standards across multiple industries.
Circet
Venture Round in 2017
Circet is a telecommunications infrastructure services company that designs, builds, and maintains fixed and mobile networks for operators and large accounts. It provides turnkey projects and process industrialization to shorten deployment cycles and enhance efficiency, and is recognized for its agility and flexibility in delivering network rollouts and ongoing maintenance. The company offers repair and maintenance services for telecom infrastructure to support reliable, long-term network performance.
OCTIMET Oncology
Series A in 2017
Founded in 2016, OCTIMET Oncology is a Belgian company dedicated to developing MET kinase inhibitors for cancer treatment. Its strategy involves innovative patient selection and pharmacodynamic biomarker-based approaches.
Bankin' is a European leader in mobile money management, serving over 1.5 million users across France, England, Spain, and Germany. It offers an independent, user-centric platform that combines intelligent algorithms with human coaching to provide personalized savings, credit, and insurance options.
Enterome develops innovative cancer treatments focusing on generating powerful, long-lasting immune responses using its proprietary OncoMimic technology. The company aims to overcome immune tolerance against cancer cells, with applications across various solid tumors. Its most advanced programs are in Phase 2 clinical trials for hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.
Themis Bioscience
Series B in 2016
Themis Bioscience N.V. is a clinical-stage biopharmaceutical company headquartered in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead product candidate, MV-CHIK, has completed Phase II clinical trials for chikungunya treatment. Themis is also engaged in developing vaccines for various health threats, including cancer, Zika virus, Lassa fever, and MERS. Themis leverages its advanced understanding of immune system mechanisms through its innovative vaccine platform, focusing on both emerging and specialized indications. The company has established research collaborations and exclusive licensing agreements to enhance its development capabilities, positioning itself as a strategic partner for leading biotechnology and pharmaceutical firms.
Ducatillon
Acquisition in 2016
Ducatillon is a retailer specializing in the distribution of breeding equipment for pets, poultry, and small livestock such as rabbits and goats, catering primarily to amateur enthusiasts and families. Additionally, the company offers hunting equipment and accessories tailored to recreational hunters and their dogs. Ducatillon's product range aims to provide customers with branded, durable goods suitable for hobby farming and outdoor leisure activities.
Oxatis SA is a provider of e-commerce technology solutions based in Marseille, France, established in 2001. The company specializes in offering Software as a Service (SaaS) tools designed for small businesses to create comprehensive websites and establish an online presence. Its offerings include online content management system (CMS) software, hosting services, and integrated shopping cart solutions. These tools enable users to sell products online with minimal technical expertise and investment, making e-commerce accessible to a broader range of entrepreneurs.
Bizay is a technology platform that provides an extensive catalogue of customizable products, operating across Europe, North and South America. The company focuses on digitalizing the product customization industry, allowing local manufacturers, brands, and wholesalers to offer a wide range of customizable items. Bizay targets multiple customer segments, including businesses seeking to sell customized products, small and medium-sized enterprises needing specific product solutions, and major brands leveraging the company's technology for their own customization needs. Its offerings encompass various product categories, such as promotional items, packaging, home and garden goods, fashion and sports products, and beauty and health items. Moreover, Bizay emphasizes sustainability and social responsibility, collaborating with partners that implement inclusion programs and utilizing recycled materials in its products. By optimizing supply chain processes, the company significantly reduces production costs, making customization accessible for a diverse clientele.